Seres Therapeutics, Inc.
MCRB
$19.44
$1.126.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 85.97M | 72.95M | 136.00K | -25.48M | -162.11M |
| Total Depreciation and Amortization | 13.82M | 14.19M | 14.67M | 14.92M | 15.20M |
| Total Amortization of Deferred Charges | 463.00K | 948.00K | 1.41M | 1.82M | 1.75M |
| Total Other Non-Cash Items | -109.87M | -106.48M | -99.32M | -97.72M | 27.32M |
| Change in Net Operating Assets | -50.33M | -68.07M | -65.51M | -50.77M | -63.97M |
| Cash from Operations | -59.94M | -86.46M | -148.61M | -157.23M | -181.80M |
| Capital Expenditure | -434.00K | -352.00K | -380.00K | -1.17M | -2.84M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 141.27M | 141.27M | 141.27M | 141.27M | -- |
| Other Investing Activities | 0.00 | 1.40M | 1.40M | 1.40M | 1.40M |
| Cash from Investing | 140.84M | 142.32M | 142.29M | 141.51M | -1.43M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -127.91M | -127.91M | -127.91M | -127.91M | 0.00 |
| Issuance of Common Stock | 19.95M | 19.95M | 37.53M | 42.23M | 26.63M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -107.95M | -107.95M | -90.37M | -85.68M | 26.63M |
| Foreign Exchange rate Adjustments | -1.00K | -1.00K | -1.00K | 0.00 | 1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -27.06M | -52.10M | -96.69M | -101.40M | -156.60M |